Variant report
Variant | nsv970347 |
---|---|
Chromosome Location | chr6:119841473-119846393 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:27115305..27118047-chr6:119845480..119847111,2 | K562 | blood: | |
2 | chr6:119841673..119843483-chr6:119844681..119847300,2 | K562 | blood: | |
3 | chr6:119843554..119849464-chr6:119857020..119861311,6 | K562 | blood: | |
4 | chr6:119843554..119845445-chr6:119857020..119859893,3 | K562 | blood: | |
5 | chr6:119841673..119843483-chr6:119844681..119847300,2 | K562 | blood: | |
6 | chr6:119845567..119847113-chr6:119965948..119967870,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000265565 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs369011927 | chr6:119841509-119841510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs59315027 | chr6:119841522-119841523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549066318 | chr6:119841608-119841609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs191980749 | chr6:119841635-119841636 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs182969912 | chr6:119841711-119841712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560070182 | chr6:119841725-119841726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs12195597 | chr6:119841737-119841738 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs539033355 | chr6:119841776-119841777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571444130 | chr6:119841785-119841786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs188050548 | chr6:119841786-119841787 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs9481935 | chr6:119841878-119841879 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs553799976 | chr6:119841933-119841934 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192507755 | chr6:119841970-119841971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs13204414 | chr6:119841977-119841978 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs77188244 | chr6:119841993-119841994 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs371589499 | chr6:119842033-119842034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs576174488 | chr6:119842045-119842046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs544992245 | chr6:119842059-119842060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558870121 | chr6:119842071-119842072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs183781150 | chr6:119842076-119842077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541683892 | chr6:119842099-119842100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187710305 | chr6:119842111-119842112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192750296 | chr6:119842116-119842117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs17081365 | chr6:119842310-119842311 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs562569182 | chr6:119842338-119842339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572533296 | chr6:119842393-119842394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs147207379 | chr6:119842398-119842399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533765063 | chr6:119842466-119842467 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs6569083 | chr6:119842478-119842479 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs571191342 | chr6:119842503-119842504 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114783160 | chr6:119842505-119842506 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573734657 | chr6:119842523-119842524 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567248867 | chr6:119842532-119842533 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs536034845 | chr6:119842540-119842541 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7740612 | chr6:119842563-119842564 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs569522964 | chr6:119842595-119842596 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs538700727 | chr6:119842614-119842615 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148693829 | chr6:119842627-119842628 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558805139 | chr6:119842680-119842681 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs114197566 | chr6:119842798-119842799 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534743999 | chr6:119842835-119842836 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs17081375 | chr6:119842871-119842872 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs141384487 | chr6:119842881-119842882 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544024392 | chr6:119842909-119842910 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563834671 | chr6:119842910-119842911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs73533179 | chr6:119842956-119842957 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs75231051 | chr6:119843047-119843048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs114660993 | chr6:119843073-119843074 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs527255867 | chr6:119843074-119843075 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs189508642 | chr6:119843169-119843170 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 21364760 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Hypoplastic | 20877625 | CNVD |
Hypotonia | 20877625 | CNVD |
Mental retardation | 20877625 | CNVD |
Microcephaly | 20877625 | CNVD |
brachycephaly | 20877625 | CNVD |
epicanthic folds | 20877625 | CNVD |
micrognathia | 20877625 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 18698023 | CNVD |
Mental retardation | 18854857 | CNVD |
Leukemia | 18688285 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:119825800-119850200 | Weak transcription | Primary hematopoietic stem cells | blood |
2 | chr6:119834200-119842400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr6:119839200-119844600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr6:119839400-119848800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr6:119839600-119844200 | Weak transcription | Dnd41 | blood |
6 | chr6:119840200-119841800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
7 | chr6:119841600-119841800 | Enhancers | Sigmoid Colon | Sigmoid Colon |
8 | chr6:119841800-119842000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
9 | chr6:119842000-119842800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
10 | chr6:119842400-119842600 | Enhancers | Sigmoid Colon | Sigmoid Colon |
11 | chr6:119842400-119842800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr6:119842600-119843000 | Enhancers | Rectal Mucosa Donor 31 | rectum |
13 | chr6:119842800-119843200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
14 | chr6:119842800-119847400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr6:119843200-119844600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
16 | chr6:119844200-119845800 | Enhancers | Dnd41 | blood |
17 | chr6:119844600-119845600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
18 | chr6:119844600-119845800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
19 | chr6:119844800-119845400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
20 | chr6:119845800-119847800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |